SAINT PAUL, Minn. — Today, the Minnesota House of Representatives approved the Alec Smith Insulin Affordability Act, which will help Minnesotans access affordable insulin in emergency situations and long-term.
“The cost of insulin has skyrocketed in the last ten years, forcing thousands of people to ration the lifesaving medication,” said Rep. Patty Acomb (DFL – Minnetonka), who voted in support of the legislation. “Today, we passed legislation to help Minnesotans get the insulin they need at a price they can afford. Many Minnesotans fought tirelessly for this important legislation, and I was honored to vote for it.”
The Alec Smith Insulin Affordability Act is named after a young man who lost his life because he could not afford his insulin. The legislation ensures that Minnesotans who are in urgent need of insulin but cannot afford it can access an emergency 30-day supply at their pharmacy for a co-pay of $35. Pharmaceutical manufacturers are required to participate in the solution by reimbursing pharmacies for these emergency supplies.
The legislation also helps Minnesotans access affordable insulin long-term by requiring insulin manufacturers to create patient assistance programs. Eligible individuals could access a 90-day supply of insulin for $50 or less through these programs. If they don’t comply, insulin manufacturers could be fined up to $3.6 million a year, doubling in the second year.
A copy of the legislation can be found here. The Alec Smith Insulin Affordability Act was approved by the Minnesota Senate and is expected to be signed by Governor Walz.